The U.S.-U.A.E. Business Council-hosted lunch and discussion will feature remarks and insights from Suhail Mahmood Al Ansari, Executive Director of Mubadala Healthcare. Mr. Al Ansari will speak about the current progress and future development of the United Arab Emirates’ healthcare sector, and specifically those initiatives for which Mubadala has authority for execution. Following his keynote remarks, the floor will be opened for a question and answer session. For your reference, Mr. Al Ansari’s biography can be found below.

Suhail Mahmood Al Ansari, Executive Director, Mubadala Healthcare

Suhail is Executive Director of the Mubadala Healthcare and heads the business unit. Prior to joining the Company, Suhail worked with Dubai Holding as head of Marketing & Communications at Dubai Healthcare City. He was seconded to Dubai Holding from the Executive Office of the Crown Prince of Dubai, where he was a member of the Strategy department.
Education: Bachelor’s degree in Chemical Engineering from the University of Surrey, UK; Masters of Science degree in Finance from Boston College, U.S.A.

Suhail is Chairman of the Board of Imperial College London Diabetes Centre, Abu Dhabi Knee & Sports Medicine Centre, Tawam Molecular Imaging Centre, Capital Health Screening Centre, National Reference Laboratory, Arzanah Medical Complex and Healthpoint. He is a member of the board of directors of Agility Abu Dhabi, and Cleveland Clinic Abu Dhabi.